completion

Synopsys Completes Acquisition of Ansys

Creating the Leader in Engineering Solutions from Silicon to Systems News Highlights: Combines leaders in silicon design, IP and simulation and…

2 months ago

Azerbaijan’s Sovereign Wealth Fund to Acquire Minority Stake in 402 MW of Solar Assets in Italy from Enfinity Global

SOFAZ to acquire 49% stake in a 402 MW portfolio of solar power plants in Italy from Enfinity Global who…

2 months ago

JA Mining Expands Renewable Mining Infrastructure in North America Post Completion of Independent Security Audit

DENVER, CO, July 16, 2025 (GLOBE NEWSWIRE) -- In response to rising demand for sustainable and secure digital asset participation,…

2 months ago

KuCoin Completes Independent Hacken-Audited Proof of Reserves

Achieves the 32nd Consecutive Month of Publishing PoR Reports, Sustaining over 100% Coverage VICTORIA, Seychelles, July 10, 2025 /PRNewswire/ --…

2 months ago

Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study

TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a…

2 months ago

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

July 02, 2025 03:00 ET  | Source: Belite Bio, Inc -  500 subjects enrolled across the United States, the United…

2 months ago

Amrize Debuts as Independent, Publicly Traded Company

100% spin-off from Holcim complete Amrize begins trading on NYSE and SIX under ticker symbol “AMRZ” Amrize to be the…

3 months ago

Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026

COPENHAGEN, Denmark, June 18, 2025 /PRNewswire/ -- Droplet IV today announced the successful completion of a $2 million funding round…

3 months ago

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in…

3 months ago

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today…

3 months ago